Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-11
2000-08-22
Powers, Fiona T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514380, 548241, 548243, 548244, 548245, 548246, A61K 31422, A61K 31423, C07D26116, C07D26112
Patent
active
061073202
ABSTRACT:
Compounds of the formula ##STR1## inhibit the activity of endothelin. The symbols are defined as follows: R.sup.1, R.sup.2 and R.sup.3 are each independently
REFERENCES:
patent: 2888455 (1959-05-01), Kano et al.
patent: 4415496 (1983-11-01), Harris et al.
patent: 4661479 (1987-04-01), Wyvratt, Jr. et al.
patent: 5236928 (1993-08-01), Chakravarty et al.
patent: 5270313 (1993-12-01), Burri et al.
patent: 5292740 (1994-03-01), Burri et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5464853 (1995-11-01), Chan et al.
patent: 5514691 (1996-05-01), Chan et al.
patent: 5514696 (1996-05-01), Murugesan et al.
patent: 5571821 (1996-11-01), Chan et al.
CA:87639g, 1969, Synthesis of flourine-containing sulfonamide derivatives. Saito et al. p. 324, 1969.
CA: 120511w, 1970, Manufacture of new sulonamide derivatives. Saito, p. 368, 1970.
CA: 41908v, 1980, New synthesis. . .derivatives. I. Migliara et al., p. 782, 1980.
S. Norio et al., Chemical Abstracts. vol. 70, No. 19, (1969), 87639g.
T. Saito, Chemical Abstracts, vol. 73, No. 23, (1970), 120511w.
Derwent Abstract No. 88-289069/41 Feb. 27, 1987.
Derwent Abstract No. 88-195835/28 Nov. 26, 1986.
Derwent Abstract No. 88-061295/09 Jul. 9, 1986.
Derwent Abstract No. 87-152485/22 Oct. 11, 1985.
Derwent Abstract No.62299 E/30 Dec. 11, 1980.
Derwent Abstract No. 40927 D/23 Sep. 11, 1979.
Derwent Abstract No. 91-254550/35 Feb. 19, 1990.
Derwent Abstract No. 86-246709/38 Nov. 27, 1985.
Derwent Abstract No. 35012 K/15 Sep. 24, 1981.
Allen et al., "Preparation. . . antagonists", CA116(11):106284Z, p. 778, 1992.
R. D. Desai et al., Chemical Abstracts, vol. 71, No. 11, (1969) 49825c.
R. D. Desai et al., Chemical Abstracts, vol. 71, No. 3, (1969) 12872q.
Wang et al., "Nitrile. . . sinomin", CA 108:94444w, p. 651, 1988.
Khanna, "Oral . . . formulation", CA 115:35728p, p. 415, 1991.
Stein et al., "The Discovery. . . 1-naphthalenesulfonamide", CA120:182333n, p. 21-22, 1994.
Murugesan et al., "N-(heteroaryl). . . antagonists", CA120:270370c, p. 1067, 1994.
Vree et al., "Renal excretion. . . function." CA97:84685r, p. 23, 1982.
Oie, "Pharmacokinetics. . . dosing", CA102:197512x, p. 18, 1985.
P. G. Ferrini et al., Angew. Chem. Internat. Edit., vol. 2, No. 2 (1963) p. 99.
A. M. van Leusen, et al., "Synthesis. . . Compounds", J. Org. Chem., vol. 41, No. 4, (1976), pp. 69-71.
W. J. Hammar et al., J. Heterocyclic Chem., vol. 18, (1991) pp. 885-888.
A. M. van Leusen et al., Tetrahedron Letters, No. 23, (1972), pp. 2369-2372.
Chan et al., "Identification of a New Class of ET.sub.A Selective Endothelin Antagonists by Pharmacophore Directed Screening", Biochemical and Biophysical Research Communications, vol. 201, No. 1, May 30, 1994, pp. 228-234.
Stein et al., "The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ET.sub.A Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1--naphthalenesulfonamide" , J. Med. Chem., vol. 37, No. 3, Feb. 4, 1994, pp. 329-331.
Hunt John T.
Murugesan Natesan
Babajko Suzanne E.
Bristol-Myers Squibb Co.
Hermenau Ronald S.
Powers Fiona T.
LandOfFree
Phenyl sulfonamide endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl sulfonamide endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl sulfonamide endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581502